NDUFA4L2 Antibody
- 
								中文名稱:NDUFA4L2兔多克隆抗體
- 
								貨號:CSB-PA003385
- 
								規(guī)格:¥1090
- 
								圖片:
- 
								其他:
產(chǎn)品詳情
- 
											Uniprot No.:
- 
											基因名:
- 
											別名:FLJ26118 antibody; NADH dehydrogenase (ubiquinone) 1 alpha subcomplex 4 like 2 antibody; NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 antibody; NADH ubiquinone oxidoreductase MLRQ subunit homolog antibody; NADH-ubiquinone oxidoreductase MLRQ subunit homolog antibody; Ndufa4l2 antibody; NUA4L_HUMAN antibody; NUOMS antibody
- 
											宿主:Rabbit
- 
											反應(yīng)種屬:Human,Mouse
- 
											免疫原:Synthesized peptide derived from the C-terminal region of Human NDUFA4L2.
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標(biāo)記方式:Non-conjugated
- 
											抗體亞型:IgG
- 
											純化方式:The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 
											產(chǎn)品提供形式:Liquid
- 
											應(yīng)用范圍:WB, ELISA
- 
											推薦稀釋比:Application Recommended Dilution WB 1:500-1:2000 ELISA 1:20000 
- 
											Protocols:
- 
											儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
Most popular with customers
- 
                                            
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
  
 













 
         
           
  
          